60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 162 | 316 | 529 | 308 | 256 |
| Cost of Goods | 86 | 121 | 538 | 50 | 73 |
| Gross Profit | 76 | 196 | -9 | 258 | 183 |
| Operating Expenses | 2,257 | 2,234 | 2,854 | 1,913 | 2,167 |
| Operating Income | -2,095 | -1,917 | -2,326 | -1,605 | -1,911 |
| Interest Expense | 1 | 3 | 2 | 1 | 2 |
| Other Income | 6 | 480 | 10 | -127 | 35 |
| Pre-tax Income | -2,090 | -1,441 | -2,317 | -1,733 | -1,877 |
| Income Tax | N/A | N/A | 0 | 2 | N/A |
| Net Income Continuous | -2,090 | -1,439 | -2,317 | -1,735 | -1,877 |
| Minority Interests | -1 | -1 | -1 | -1 | -1 |
| Net Income | $-2,089 | $-1,439 | $-2,316 | $-1,734 | $-1,877 |
| EPS Basic Total Ops | -1.28 | 2.16 | -2.64 | -5.00 | -6.25 |
| EPS Basic Continuous Ops | -1.21 | 2.08 | -2.52 | -4.71 | -5.85 |
| EPS Diluted Total Ops | -1.28 | 2.16 | -2.64 | -5.00 | -6.25 |
| EPS Diluted Continuous Ops | -1.21 | 2.08 | -2.52 | -4.71 | -5.85 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -2.64 | -5.00 | -6.24 |
| EBITDA(a) | $-2,025 | $-1,850 | $-2,259 | $-1,541 | $-1,850 |